Skip to main content

Advertisement

ADVERTISEMENT

Volume 18 - Issue 2 - February, 2006

Insights

Commentary
08/01/2008
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of...
08/01/2008
Journal of Invasive Cardiology

Feature

Original Contribution
08/01/2008
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement